GEMCITABINE
Clinical trials for GEMCITABINE explained in plain language.
Never miss a new study
Get alerted when new GEMCITABINE trials appear
Sign up with your email to follow new studies for GEMCITABINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo cocktail aims to fight childhood germ cell tumors that return
Disease control Recruiting nowThis study looks at how well a combination of four chemotherapy drugs (gemcitabine, docetaxel, melphalan, and carboplatin) followed by a stem cell transplant works in children and teens up to age 21 whose germ cell tumors have come back or not responded to treatment. Researchers …
Matched conditions: GEMCITABINE
Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Immunotherapy combo shows promise in bladder cancer trial
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug durvalumab to standard chemotherapy before and after bladder cancer surgery is safe and effective. About 150 people with muscle-invasive bladder cancer will receive durvalumab plus either ddMVAC or gemcitabine/cisplatin chemo…
Matched conditions: GEMCITABINE
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC